Literature DB >> 6667252

Treatment of DIC with antithrombin III concentrates.

Y Sakata, N Yoshida, M Matsuda, N Aoki.   

Abstract

We administered AT III concentrates to 21 patients with DIC who failed to respond initially to heparin therapy. About 60% of these 21 patients were effectively treated with AT III concentrates by enhancing the effect of heparin and alleviating the burden of excessive plasma transfusions on the cardiovascular system.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6667252     DOI： 10.1159/000408471

Source DB:  PubMed          Journal:  Bibl Haematol        ISSN： 0067-7957


  4 in total

1.  Fatal intraoperative disseminated intravascular coagulation.

Authors:  J H Urbanowicz; J B Brodsky
Journal:  West J Med       Date:  1989-12

2.  Use of antithrombin III in critical patients.

Authors:  J M Díaz-Cremades; R Lorenzo; M Sánchez; M J Moreno; M J Alsar; J M Bosch; L Fajardo; D González; D Guerrero
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

3.  Antithrombin III concentrate in the treatment of fulminant hepatic failure.

Authors:  K Fujiwara; K Okita; K Akamatsu; H Abe; Y Tameda; T Sakai; N Inoue; K Kanai; N Aoki; H Oka
Journal:  Gastroenterol Jpn       Date:  1988-08

4.  Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III.

Authors:  K Fujiwara; I Ogata; Y Ohta; K Hirata; Y Oka; S Yamada; Y Sato; N Masaki; H Oka
Journal:  Gut       Date:  1988-08       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.